Coda Octopus Group (CODA)
Coda Octopus is a monopoly hiding in plain sight. It is the sole global provider of real-time volumetric (3D/4D/5D/6D) underwater imaging sonar -- technology that lets operators "see" through zero-visibility water in real time, the way a camera sees in air. The company also builds the DAVD diver heads-up display for the U.S. Navy and, since late 2024, makes acoustic sensors and hydrophones through its Precision Acoustics acquisition.
At 38x trailing earnings the stock is not cheap. But if the Navy DAVD fleet rollout and NanoGen AUV adoption ramp as management expects, the current price could look like a bargain in 2-3 years.
Identity
| Field | Detail |
|---|---|
| Full name | Coda Octopus Group, Inc. |
| Ticker | CODA (NASDAQ) |
| HQ | Orlando, Florida |
| Founded | 1994 |
| Employees | ~100 |
| FY ends | October 31 |
| Market cap | ~$158M (Mar 2026) |
| Enterprise value | ~$130M (net cash $28.7M) |
| Website | codaoctopusgroup.com |
Business Segments
| Segment | FY2025 Revenue | % Total | Description |
|---|---|---|---|
| Marine Technology | $13.2M | 50% | Echoscope real-time 3D/4D/5D/6D sonar, DAVD diver displays, GeoSurvey software, GNSS |
| Defense Engineering | $7.9M | 30% | Engineering services for defense customers (Salt Lake City, Portland UK) |
| Acoustics/Sensors/Materials | $5.4M | 20% | Hydrophones, acoustic sensors, medical/NDT materials (Precision Acoustics Ltd, acquired Oct 2024) |
Operations Footprint
| Location | Function |
|---|---|
| Orlando, FL | Corporate HQ, Marine Technology ops |
| Edinburgh, Scotland | R&D, sonar manufacturing (12,070 sq ft) -- core design and assembly |
| Copenhagen, Denmark | Marine Technology operations |
| Salt Lake City, UT | Defense engineering services |
| Portland, Dorset, UK | Defense engineering (Martech) |
| Dorchester, Dorset, UK | Precision Acoustics -- sensors, hydrophones |
Asset-light model. The value is in the IP, patents, and engineering talent -- not the facilities.
Thesis
Coda Octopus is the only company in the world that makes real-time volumetric underwater imaging sonar. Its Echoscope product line and DAVD diver display system are being adopted by the U.S. Navy and allied navies at an accelerating pace, with no competitive alternatives available. If the DAVD fleet rollout and NanoGen AUV integration programs scale as expected, this $26.6M revenue business has a credible path to $50M+ revenue within 3-4 years, which at current margins would drive a significant re-rating.
Single most important thing that must go right: The DAVD Authorization for Navy Use (ANU) approval must clear, opening the path to fleet-wide procurement beyond the current 9 Navy commands.
Target price: $18-20 (12-18 months), based on ~30x FY2026E earnings with upside from M&A and DAVD ramp. Expected return 28-42%.
Conviction: Medium. The technology moat is real and deep, but the stock has already tripled from its 52-week low. Timing is the question, not quality.
Business
First Principles -- The Technology
Water kills visibility. Light is absorbed and scattered within meters. Below about 10 meters of depth in most conditions -- and often at the surface in turbid harbors, rivers, or construction zones -- cameras are useless. Traditional multibeam sonar sends acoustic pings and measures bounces, producing 2D data: a fan of beams sweeping across the seafloor as a vessel moves, building a map strip by strip. You get a static picture of the bottom, assembled after the fact. No moving objects. No real-time volumetric view.
Coda's Echoscope does something fundamentally different. It fires acoustic energy in a wide volumetric cone and processes returns to produce a full 3D image of everything in the field of view -- including moving objects -- in real time, from a stationary platform.
The key physics:
- Acoustic transmission: Broadband acoustic pulse into a wide field of view (typically 50x50 degrees or wider)
- Volumetric reception: 2D receiver array captures reflected energy across the entire field simultaneously
- 3D beamforming: Proprietary parallel processing algorithms form thousands of beams in both azimuth and elevation simultaneously, creating a volumetric grid
- Real-time rendering: Processed data rendered as live 3D scene (multiple fps), like a video camera using sound instead of light
Result: operators see a live 3D scene underwater, in zero visibility, including moving objects.
Why it is hard to replicate: Traditional multibeam processes ~512 data points per ping. Coda's Echoscope PIPE captures and processes up to 81 million data points per ping in its 5D/6D variants -- 5-6 orders of magnitude more data, in real time. The challenges are massive parallel processing, signal-to-noise management across thousands of simultaneous beams, and precise acoustic transducer manufacturing using specialized piezoelectric materials (which is exactly why CODA acquired Precision Acoustics, their former supplier).
Product Line
- Echoscope PIPE: Core real-time 3D volumetric imaging sonar. Multiple variants for different ranges.
- Echoscope PIPE NanoGen: Next-gen ultra-compact variant for AUV/autonomous platform integration. Launched FY2025.
- Echoscope CIVS: Ultra-high resolution short-range variant (>1 MHz) for fine-detail 3D imaging.
- DAVD (Diver Augmented Vision Display): Heads-up display for military/commercial divers integrating Echoscope imagery. Tethered (operational at 9 Navy commands) and untethered (DUS, 16 units to SOCOM).
- GeoSurvey: Sidescan sonar and sub-bottom profiler software/hardware.
- Survey Engine: Post-processing software.
Segment Deep-Dive
Marine Technology ($13.2M, 50% of revenue) -- the crown jewel.
Echoscope (71.9% of Marine Tech = ~$9.5M): ASP likely $200K-$500K+ per system. Customers are navies, offshore energy companies, marine construction firms. Growth +30.5% in FY2025. Competitive alternatives from Teledyne (SeaBat) and Kongsberg are multibeam, not real-time 3D.
DAVD (28.1% of Marine Tech = ~$3.7M): Two variants. Tethered operational at 9 Navy commands. Untethered (DUS) had 16-unit order from SOCOM (Mar 2025). $1.5M bundled order (DAVD+Echoscope, May 2025). If ANU approval clears, opens fleet-wide deployment. No competitive alternative -- DAVD is the only approved diver HUD for the U.S. Navy.
Defense Engineering ($7.9M, 30% of revenue): Traditional services business. Lower margins but provides steady recurring revenue and keeps CODA embedded in defense supply chains. Growth +5.6% in FY2025.
Acoustics/Sensors/Materials ($5.4M, 20% of revenue): Precision Acoustics Ltd, acquired Oct 2024 for $5.16M net cash (+$1.29M earn-out). Designs hydrophones and acoustic sensors for medical imaging and NDT. Was CODA's former supplier of core acoustic materials. Hit year-one earn-out targets. Lower gross margins (~60% est. vs 70%+ Marine Tech), which is why consolidated margins compressed from 69.8% to 66.5%.
Value Chain
[Acoustic Materials & Sensors] -> [Sonar Subsystems] -> [Imaging Sonar Systems] -> [Defense/Commercial Operators]
* PAL segment * Echoscope/DAVD Navy, Oil & Gas, Wind
CODA occupies two layers: upstream materials/sensors (PAL) and finished imaging sonar. This vertical integration is deliberate moat-building -- they now control the acoustic materials that make their core product work.
Customer concentration: 68% from top 3 clients. This is the biggest operational risk. Losing a major Navy program would be a revenue cliff.
End Markets & TAM
Global sonar systems market: ~$5.25B (2025), growing 4.4% CAGR to $6.5B by 2030. Underwater 3D imaging sonar segment projected to reach $1.5B by 2033 at 7.8% CAGR.
CODA's SAM: $300M-$500M (advanced imaging sonar + military diver tech + precision acoustics). Current share: sub-1% of broad sonar, but effectively 100% of the real-time volumetric imaging niche.
Secular tailwinds: Naval modernization (underwater domain awareness priority), AUV/autonomous systems growth (NanoGen), offshore wind buildout (subsea survey), subsea decommissioning (aging platforms), port/harbor security.
Competitive Landscape
| Competitor | What They Do | Threat Level |
|---|---|---|
| Teledyne (TDY) | SeaBat multibeam, marine instruments ($5.7B rev) | Closest but no real-time volumetric 3D |
| Kongsberg (KOG.OL) | Multibeam sonar, subsea systems ($3.5B rev) | Strong in survey-grade but lacks volumetric capability |
| ECA/Exail (EXA.PA) | UUVs, sonar systems (~$300M rev) | Focuses on autonomous platforms, not imaging |
| Chesapeake Tech (private) | SonarWiz software (~$10M est.) | Software niche, far less capable |
Moat assessment: A. This is one of the strongest competitive moats in the micro-cap universe. 16+ patents covering real-time volumetric sonar. 81 million data points per ping vs. competitors' ~512. 30+ years of accumulated know-how. Sole provider status. Extreme switching costs in defense. The technology gap is not something that gets closed in a year or two. Nobody has done it in 20 years of trying.
Pricing power: Significant. No alternative exists for real-time volumetric imaging. Customers cannot get this capability elsewhere.
Could Teledyne or Kongsberg develop competing tech? Theoretically, but they have had 20+ years and have not. The more realistic threat is not a competitor building the same technology -- it is the market staying niche. If real-time volumetric sonar never breaks out of current applications, CODA remains a $30-50M revenue company forever.
Management
Executive Team
| Name | Title | Tenure | Background |
|---|---|---|---|
| Annmarie Gayle | Chairman & CEO | CEO since 2011, Chairman since 2017 | Restructuring lawyer; Cambridge LLM. 12+ years advising on bank privatizations in CEE. Joined as SVP Legal 2006, restructured the company during its financial difficulties, elevated to CEO. Took CODA from OTC mess to NASDAQ-listed, debt-free growth story. |
| Blair Cunningham | President of Technology; CTO | Since 2004 (22 years) | Software developer; HND Computer Science. The technical architect behind Echoscope and DAVD. World-class domain expertise, impossible to hire off the street. |
| Gayle Jardine | Interim CFO | Since 2015 (interim since Feb 2024) | Career at HP, Agilent, Scottish Water Solutions, Honeywell. CIMA qualified 1996. "Interim" for 2+ years is a governance flag. |
| Niels Sondergaard | Sales Director, Products | Long-tenured | Married to CEO. Largest individual shareholder (~18-20%). Based in Denmark. |
| Dr. Angus McFadzean | Director (co-founder) | Co-founded in 1994 | PhD Sonar Interpretation, Heriot-Watt. Former R&D Director. 30 years of institutional knowledge. |
Board of Directors
| Director | Independent? | Key Expertise |
|---|---|---|
| Michael Hamilton | Yes | Former PwC audit partner (15 years); CPA; Audit (Chair), Comp/Gov (Chair) |
| Robert Harcourt | Yes | Retired KPMG partner (40+ years); former PCAOB Assoc. Director; Nominating (Chair) |
| BG Anthony Tata (Ret.) | Yes | Former acting #3 at DoD; 82nd/101st Airborne, 10th Mountain commands |
| Gwenael Rouy-Poirier | Yes | Former CFO of GKN Aerospace, Nobel Biocare; aerospace/defense finance |
4 of 6 independent. Audit committee is outstanding -- two former Big Four partners plus a PCAOB official. That is unusual depth for a micro-cap. General Tata provides defense relationships. Board quality is strong.
Insider Ownership & Skin in the Game
| Name | Role | Shares | % Outstanding | Est. Value |
|---|---|---|---|---|
| Niels Sondergaard | Sales Dir / spouse of CEO | ~2.05M | ~18.2% | ~$27.8M |
| J. Steven Emerson | 10% owner | 1.30M | 11.6% | ~$17.7M |
| Bryan Ezralow | 10% owner | 1.07M | 9.5% | ~$14.6M |
| Annmarie Gayle | CEO | 95K (direct) | 0.8% direct, 21.1% household | ~$1.3M direct |
| G. Tyler Runnels | Former 10% owner | 876K | 7.8% | ~$11.9M |
| Blair Cunningham | President of Tech | 38K | <1% | ~$520K |
Total insider ownership: ~45%. The Gayle-Sondergaard household controls ~21% -- genuinely significant skin in the game. Sondergaard's wealth appears predominantly in CODA.
Recent insider activity: Selling dominates. Sondergaard sold ~206K shares ($1.7M) in Sept-Oct 2025 at ~$8. These were discretionary sales (no 10b5-1 plan). Not catastrophic given his ~$27M remaining position, but directionally negative. No open-market buying by the CEO in the last 12 months.
Compensation
| Officer | FY2024 Total Comp | Notes |
|---|---|---|
| Annmarie Gayle (CEO) | $405,000 | $305K salary + $100K bonus. Zero stock awards. |
| Blair Cunningham | $265,932 | $225K salary (raised to $270K Feb 2025) |
| Gayle Jardine (Interim CFO) | $171,648 | GBP 82K + GBP 6K/mo interim supplement |
CEO comp at $405K is modest for a ~$150M market cap (median peer: ~$570K). She takes no stock-based compensation -- zero dilution from the CEO. SBC company-wide is just $224,786 (0.85% of revenue) -- best-in-class. Share count barely moves: 11.1M to 11.27M over 3 years (+1.5% cumulative). No ATM, no shelf, no warrant overhang.
CEO employment agreement: No definitive term. 12 months' notice to resign. Termination without cause: annual salary + $150K separation bonus = ~$455K total severance. Modest. No golden parachute. Bonus targets undisclosed (she gets the full $100K every year -- could be a rubber stamp).
Capital Allocation Track Record
M&A: A. Three acquisitions in 18 years -- patient and disciplined.
- Colmek (2007): bought for $2.1M, now generates ~$7.9M defense revenue. Home run.
- PAL (2024): bought for ~$5.2M, already generating $5.4M revenue. Hit year-one earn-out. Paid ~1x revenue for a profitable business.
- Management signals intent to close another in FY2026 ("very keen").
Buybacks: F. No authorized repurchase programs ever. The stock spent extended periods at $5-6 -- below tangible book value in some periods -- while $28.7M sat in the bank. Management left significant value on the table. Cash earning Treasury yields while your stock trades at 5x earnings is poor capital stewardship.
Dilution: A. Minimal. Near-zero SBC. Self-funded operations.
Capital allocation grade: B. Great M&A discipline and zero dilution, but the cash hoarding without a return framework is a meaningful miss.
Management Credibility
Coda does not provide formal numerical guidance. On earnings calls, management makes qualitative claims. Where analyst consensus exists, they have consistently met or beaten:
| Period | Consensus EPS | Actual | Result |
|---|---|---|---|
| FY2024 Q4 | $0.10 | $0.32 | Beat +220% |
| FY2025 Q1 | $0.01 | $0.06 | Beat +500% |
| FY2025 Q2 | $0.05 | $0.08 | Beat +60% |
| FY2025 Q3 | ~$0.11 | $0.11 | In-line |
| FY2025 Full Year | ~$0.37 | $0.37 | In-line |
Follow-through rate: 100% on trackable claims. They delivered on DAVD untethered (said "anticipates first sales in FY2025," delivered 16 units to SOCOM). They delivered on PAL (closed, hit earn-outs). Pending: DAVD ANU approval ("expected close to end of Q2 FY2026"), European Navy training (Q2), NanoGen procurement decisions ("could be made in early 2026").
Weasel language frequency: Low. The hedging is appropriate for a company selling into government procurement cycles where timelines genuinely are uncertain.
Guidance tendency: Conservative / Straight Shooter. They say relatively little but generally deliver on what they say.
Management DD Verdict
| Dimension | Rating | Key Finding |
|---|---|---|
| Skin in the Game | Green | Gayle-Sondergaard family ~21%. Total insiders ~45%. Household wealth concentrated. |
| Shell / Cross-Holdings | Green | Clean structure. No related-party transactions. Proxy says "None." |
| Capital Allocation | Green | Disciplined M&A, minimal dilution, $28.7M cash, zero debt. |
| Compensation | Yellow | Modest ($405K total), but bonus targets undisclosed. No CEO equity incentives. Interim CFO 2+ years. |
| Credibility | Green | 100% follow-through on trackable claims. Low weasel language. |
| Governance | Yellow | Combined CEO/Chairman, no lead independent director. Cunningham classified "independent" despite being a named exec. |
| Litigation | Green | Nothing found. Clean. |
| Overall | B+ | Competent, aligned, frugal operators with modest governance imperfections. No red flags. |
Green flags: 45% insider ownership, CEO comp at $405K with near-zero SBC, clean corporate structure, disciplined M&A (3 deals in 18 years, all accretive), outstanding audit committee, self-funded operations, 100% management follow-through.
Yellow flags: Combined CEO/Chairman without lead independent director. Cunningham's questionable "independent" classification. CEO bonus targets undisclosed. Permanent CFO needed. No capital return framework. Sondergaard's discretionary selling. Key-person risk on both Gayle and Cunningham with no succession plan.
Red flags: None identified.
Financials
Fiscal year ends October 31. FY2025 = year ended Oct 31, 2025.
Valuation Snapshot (Mar 2026)
| Metric | Value |
|---|---|
| Market cap | ~$158M |
| Enterprise value | ~$130M |
| P/E (TTM) | 38.2x |
| Forward P/E (FY2026E) | 27.6x |
| EV/EBITDA | 16.4x |
| P/FCF | 26.3x |
| EV/Revenue | 4.9x |
| FCF yield | 3.8% |
| 52-week range | $5.76 - $17.28 |
Income Statement
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026E |
|---|---|---|---|---|---|
| Revenue | $22.2M | $19.4M | $20.3M | $26.6M | ~$30M |
| Revenue growth | -- | -12.7% | +5.0% | +30.7% | ~13% |
| Gross margin | -- | 67.3% | 69.8% | 66.5% | ~67% |
| EBIT margin | -- | 13.9% | 17.7% | 16.9% | -- |
| Net income | $4.3M | $3.1M | $3.6M | $4.1M | $5.37M (cons.) |
| EPS (diluted) | $0.38 | $0.28 | $0.32 | $0.37 | ~$0.48 |
Revenue has been lumpy, not a straight-line growth story. Dropped from $25M to $20M in COVID, dipped again in FY2023, surged in FY2025 partly on PAL ($5.4M inorganic). Organic growth in FY2025: Marine Technology +3.2%, Defense Engineering +5.6%. The FY2025 headline of +31% was heavily acquisition-driven.
Cash Flow & Balance Sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | $2.4M | $2.5M | $7.2M |
| Capex | ($2.0M) | ($0.5M) | ($1.2M) |
| Free cash flow | $0.4M | $2.0M | $6.0M |
| FCF margin | 1.9% | 9.6% | 22.7% |
| Cash | $24.4M | $22.5M | $28.7M |
| Total debt | $0 | $0 | $0 |
| Total assets | $51.8M | $57.5M | $64.5M |
| Stockholders' equity | $48.4M | $53.1M | $58.1M |
| ROIC | ~5.6% | ~6.8% | ~7.1% |
ROIC vs. WACC (~7%): Roughly breakeven to slightly value-creative. This is the weakest part of the financial story. ROIC is not high enough to justify a premium valuation purely on returns. The bull case depends on ROIC expanding as revenue scales against a relatively fixed cost base.
Incremental Margins (Last 8 Quarters)
| Quarter | Revenue | YoY Delta | Incr. GM | Incr. EBIT |
|---|---|---|---|---|
| Q1 FY2025 | $5.2M | +$0.7M | 43% | 14% |
| Q2 FY2025 | $7.0M | +$1.7M | 47% | neg. |
| Q3 FY2025 | $7.1M | +$1.6M | 50% | 0% |
| Q4 FY2025 | $7.3M | +$2.3M | 70% | 48% |
Incremental gross margins (43-70%) are at or above reported margins -- new revenue is not lower quality. Incremental EBIT is volatile due to lumpy orders and mix. Operating leverage is present but inconsistent. At scale, the 66%+ gross margin structure should deliver 20%+ EBIT.
Valuation Context
| Metric | CODA | Teledyne (TDY) | Kongsberg (KOG) | Micro-Cap Defense |
|---|---|---|---|---|
| P/E (TTM) | 38.2x | ~25x | ~30x | ~20-25x |
| EV/EBITDA | 16.4x | ~18x | ~20x | ~12-15x |
| EV/Revenue | 4.9x | ~4.5x | ~3x | ~2-3x |
DCF sanity check: 10% discount, $6M FCF growing 15% for 5 years, 3% terminal = ~$130M equity + $28.7M cash = ~$159M. Roughly where it trades. Fair value on moderate assumptions. Upside requires better-than-expected growth.
Analyst Coverage
Extremely thin: 1 analyst with a Buy and $14.28 target (revised up 27.3% in Feb 2026). FY2026E net income $5.37M. With 1 analyst, this is meaningless as consensus. The ultra-thin coverage is part of the bull case -- genuinely under-followed and potentially undervalued by the broader market.
Ownership Summary
Insiders ~45%, Institutions ~20%, Public/retail ~35%. Short interest ~0.9%, 0.3 days to cover. Negligible.
Catalysts & Risks
Near-Term Catalysts (0-12 months)
- Q1 FY2026 earnings (March 17, 2026) -- immediate catalyst. First quarter post-FY2025 breakout.
- DAVD Authorization for Navy Use (ANU) -- undergoing final approval. If cleared, opens fleet-wide procurement. "Expected close to end of Q2" FY2026.
- First European Navy DAVD training (Q2 2026) -- international expansion.
- M&A announcement -- management "very keen" to close another in FY2026.
- NanoGen defense procurement decisions -- expected early 2026.
Medium-Term Catalysts (1-3 years)
- DAVD fleet-wide deployment post-ANU
- NanoGen adoption in AUV programs
- Second or third acquisition adding recurring revenue
- Analyst coverage expansion (1 analyst today)
- Potential index inclusion as market cap grows
Secular Tailwinds
| Tailwind | Magnitude | Durability |
|---|---|---|
| Naval modernization / underwater domain awareness | High | 5-10yr+ |
| AUV/autonomous systems growth | High | 5-10yr+ |
| Offshore wind buildout | Medium | 3-5yr+ |
| Subsea decommissioning | Medium | 3-5yr |
| Port/harbor security | Low-Medium | Ongoing |
Key Risks
| Risk | Likelihood | Assessment |
|---|---|---|
| Customer concentration | Medium-High | 68% from top 3. Loss of a Navy program = revenue cliff. #1 risk. |
| Key-person risk (Gayle) | Medium | 15 years as CEO. No succession plan. No permanent CFO. 20-30% stock drop if she leaves. |
| Valuation overshoot | Medium | At 38x trailing, any earnings miss causes sharp correction. Stock tripled in 12 months. |
| Organic growth deceleration | Medium | FY2025 organic growth was mid-single digits. The 31% headline was M&A-boosted. |
| M&A execution | Medium | PAL went well, but next deal introduces new integration risk. |
| Gross margin pressure | Medium | PAL mix compressed margins 330bps. Mix will evolve with further M&A. |
| Micro-cap liquidity | Medium-High | ~$158M cap, 45% insider = limited float. Structural until company grows. |
| Defense budget uncertainty | Medium | Continuing resolutions delay contract awards. |
Bear Case
DAVD ANU approval delayed indefinitely. Defense CRs freeze procurement for 2+ years. NanoGen finds no AUV traction. M&A goes wrong. Gayle departs. Company stays a $26-30M revenue business growing mid-single digits. Downside: $8-10 (20-25x on $0.37 EPS with no growth premium) -- 30-40% below current.
Thesis Invalidation Triggers
- Revenue declines organically for 2 consecutive quarters
- Loss of a major Navy program
- CEO departure without clear succession
- Dilutive equity raise
- Gross margins below 60% for 2 consecutive quarters
- Competitor demonstrates comparable real-time volumetric sonar
Decision Log
Pre-Buy Assessment (March 15, 2026)
Category: Growth compounder. Not buying because it is cheap (it isn't at 38x trailing) -- buying because the company owns genuinely irreplaceable technology entering a period of accelerating defense demand.
Behavioral traps audit:
- FOMO risk: Stock has tripled from $5.76. Buying right before March 17 earnings adds event risk.
- Recency bias: FY2025's 31% growth was heavily M&A-boosted. Organic was mid-single digits.
- Narrative seduction: "Monopoly technology" is seductive. But 66%+ margins, growing revenue, positive FCF, zero debt -- this is not a pre-revenue story stock.
- Trap risk: Moderate.
Valuation discipline:
- DCF = roughly fair at current price.
- At 38x trailing, market prices in ~30% earnings growth. Consensus $0.48 FY2026E = 27.6x forward, more palatable but not cheap.
- Would I buy 10-15% higher? Reluctantly. Margin of safety is thin.
Technical picture (March 15):
- 51% above 50-day MA ($12.20), 87% above 200-day ($9.27). Extended.
- RSI 53 -- neutral. Not overbought. Constructive consolidation.
- Bull flag/consolidation in $13-15 range after parabolic run. Break above $17.28 = new ATH signal.
- Verdict: Wait for pullback to $11-12 zone.
Recommendation: WATCH -- Wait for Post-Earnings Entry
Entry strategy: Scale in. Do NOT take full position at current levels.
- Tranche 1 (1%): After Q1 FY2026 earnings reaction. If strong + pullback, buy $12-13.
- Tranche 2 (add to 2%): Pullback to $10-11 (200-day MA / prior breakout retest).
- Tranche 3 (add to 3%): Confirmed catalyst only (DAVD ANU, NanoGen contract).
Exit criteria:
- Sell on success: $22-25 (50-70% upside), ~35x forward on $0.65+ EPS
- Sell on failure: Revenue declines organically 2 quarters, CEO departs, competitor emerges
- Hard stop: Close below $9.00
- Trim triggers: P/E >50x TTM; Sondergaard dumps >10% of position
Maximum loss tolerance: 30% from average cost basis.
The technology is real, the moat is deep, and the people are honest. The only issue is price and timing. Patience here will likely be rewarded with a better entry.
Sources: Coda Octopus IR, FY2025 10-K (Jan 29, 2026), DEF 14A proxy (Aug 14, 2025), FY2025 Results (GlobeNewsWire), Q4 2025 Earnings Transcript (Motley Fool), StockAnalysis, Yahoo Finance, Barchart Technical Analysis, Fortune Business Insights -- Sonar Market, PAL acquisition announcement, Form 4 filings (SEC EDGAR)
Topics
- defense-technology
- green-finance
Source updates (auto-maintained)
Drop/Defense (Jul 25, 25) - 20250721_Atrium_Defence.03
Atrium Research (July 2025) names CODA among defense small-caps positioned to benefit from a multi-year NATO rearmament cycle, citing 32% YoY revenue growth in the most recent quarter, DAVD adoption wins, and the Precision Acoustics acquisition as extending reach into medical and industrial sensing.
Relevant to your thesis: Corroborates the DAVD ramp and revenue acceleration already in the wiki, and adds a NATO-budget tailwind framing consistent with the secular defense modernization thesis.
Source: dropfile://Defense/20250721_Atrium_Defence.03.pdf
Drop/Citrini Articles (Jul 6, 25) - Citrini - Electronic Warfare Basket 2025-06-20
Coda Octopus (CODA) appears in Citrini's Electronic Warfare basket at 3.43% weight, grouped alongside Teledyne, L3Harris, Lockheed, and Kratos as a named component of a 2025 EW sector thesis.
Relevant to your thesis: Institutional basket inclusion alongside defense majors signals growing recognition of CODA's defense positioning, consistent with the DAVD/Navy adoption narrative and the moat argument.
Source: dropfile://Citrini Articles/Baskets/Citrini - Electronic Warfare Basket 2025-06-20.csv